Activation of the Murine Dihydrofolate Reductase Promoter by E2F1

The E2F family of heterodimeric transcription factors plays an important role in the regulation of gene expression at the G1/S phase transition of the mammalian cell cycle. Previously, we have demonstrated that cell cycle regulation of murine dihydrofolate reductase (dhfr) expression requires E2F-mediated activation of the dhfr promoter in S phase. To investigate the mechanism by which E2F activates an authentic E2F-regulated promoter, we precisely replaced the E2F binding site in the dhfr promoter with a Gal4 binding site. Using Gal4-E2F1 derivatives, we found that E2F1 amino acids 409–437 contain a potent core transactivation domain. Functional analysis of the E2F1 core domain demonstrated that replacement of phenylalanine residues 413, 425, and 429 with alanine reduces both transcriptional activation of the dhfr promoter and protein-protein interactions with CBP, transcription factor (TF) IIH, and TATA-binding protein (TBP). However, additional amino acid substitutions for phenylalanine 429 demonstrated a strong correlation between activation of thedhfr promoter and binding of CBP, but not TFIIH or TBP. Finally, transactivator bypass experiments indicated that direct recruitment of CBP is sufficient for activation of the dhfrpromoter. Therefore, we suggest that recruitment of CBP is one mechanism by which E2F activates the dhfr promoter.

[1]  L. Magnaghi-Jaulin,et al.  The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Orphanides,et al.  A Human RNA Polymerase II Complex Containing Factors That Modify Chromatin Structure , 1998, Molecular and Cellular Biology.

[3]  N. Dyson The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[4]  S. M. Sullivan,et al.  DA-Complex Assembly Activity Required for VP16C Transcriptional Activation , 1998, Molecular and Cellular Biology.

[5]  L. Lania,et al.  Recruitment of Human TBP Selectively Activates RNA Polymerase II TATA-dependent Promoters* , 1998, The Journal of Biological Chemistry.

[6]  N. Perkins,et al.  Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein. , 1998, Biochemical pharmacology.

[7]  Michael Hampsey,et al.  Molecular Genetics of the RNA Polymerase II General Transcriptional Machinery , 1998, Microbiology and Molecular Biology Reviews.

[8]  Andrew J. Bannister,et al.  The acetyltransferase activity of CBP stimulates transcription , 1998, The EMBO journal.

[9]  M. Breuning,et al.  Conjunction dysfunction: CBP/p300 in human disease. , 1998, Trends in genetics : TIG.

[10]  D. Johnson,et al.  Role of E2F in cell cycle control and cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[11]  J. Trimarchi,et al.  E2F-6, a member of the E2F family that can behave as a transcriptional repressor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Struhl Histone acetylation and transcriptional regulatory mechanisms. , 1998, Genes & development.

[13]  D. Dean,et al.  Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.

[14]  Tony Kouzarides,et al.  Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.

[15]  L. Magnaghi-Jaulin,et al.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.

[16]  Peter E Wright,et al.  Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions , 1997, Cell.

[17]  Andrew J. Bannister,et al.  An E2F-like repressor of transcription , 1997, Nature.

[18]  H. Xiao,et al.  Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment , 1997, Molecular and cellular biology.

[19]  J. Greenblatt,et al.  Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH , 1997, Oncogene.

[20]  Jeffrey D. Parvin,et al.  RNA Helicase A Mediates Association of CBP with RNA Polymerase II , 1997, Cell.

[21]  A. Wolffe,et al.  Acetylation of general transcription factors by histone acetyltransferases , 1997, Current Biology.

[22]  J. Nevins,et al.  Distinct roles for E2F proteins in cell growth control and apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Wen‐Ming Yang,et al.  Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.

[24]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[25]  L. Chin,et al.  Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression , 1997, nature.

[26]  P. Farnham,et al.  Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain , 1997, Molecular and cellular biology.

[27]  P. Chambon,et al.  Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2. , 1997, Gene.

[28]  P. Komarnitsky,et al.  ADR1 Activation Domains Contact the Histone Acetyltransferase GCN5 and the Core Transcriptional Factor TFIIB* , 1996, The Journal of Biological Chemistry.

[29]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[30]  A. Admon,et al.  Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Levine,et al.  Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.

[32]  D. Trouche,et al.  The CBP co-activator stimulates E2F1/DP1 activity. , 1996, Nucleic acids research.

[33]  S. Goff,et al.  Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1 , 1996, Journal of virology.

[34]  D. Speicher,et al.  KAP-1, a novel corepressor for the highly conserved KRAB repression domain. , 1996, Genes & development.

[35]  B. Howard,et al.  A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A , 1996, Nature.

[36]  K. Dahlman-Wright,et al.  Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. , 1996, Biochemistry.

[37]  J. Greenblatt,et al.  Three functional classes of transcriptional activation domain , 1996, Molecular and cellular biology.

[38]  R. Evans,et al.  Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism , 1996, Molecular and cellular biology.

[39]  N. Heintz,et al.  Protein-DNA interactions at the major and minor promoters of the divergently transcribed dhfr and rep3 genes during the Chinese hamster ovary cell cycle , 1996, Molecular and cellular biology.

[40]  P. Farnham,et al.  Introduction to the E2F family: protein structure and gene regulation. , 1996, Current topics in microbiology and immunology.

[41]  S. Smale,et al.  Core promoter specificities of the Sp1 and VP16 transcriptional activation domains , 1995, Molecular and cellular biology.

[42]  S. Berger,et al.  Characterization of Physical Interactions of the Putative Transcriptional Adaptor, ADA2, with Acidic Activation Domains and TATA-binding Protein (*) , 1995, The Journal of Biological Chemistry.

[43]  Tony Kouzarides,et al.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein , 1995, Nature.

[44]  P. Farnham,et al.  The bidirectionally transcribed dihydrofolate reductase and rep-3a promoters are growth regulated by distinct mechanisms. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[45]  Winship Herr,et al.  Basal promoter elements as a selective determinant of transcriptional activator function , 1995, Nature.

[46]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[47]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[48]  L. Guarente,et al.  Yeast ADA2 protein binds to the VP16 protein activation domain and activates transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Reinberg,et al.  Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53 , 1994, Molecular and cellular biology.

[50]  P. Moore,et al.  Molecular cloning of the small (gamma) subunit of human TFIIA reveals functions critical for activated transcription. , 1994, Genes & development.

[51]  P. Farnham,et al.  Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. , 1994, Genes & development.

[52]  A. Levine,et al.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. , 1994, Genes & development.

[53]  P. Farnham,et al.  Cloning, chromosomal location, and characterization of mouse E2F1 , 1994, Molecular and cellular biology.

[54]  A. Stein,et al.  Micrococcal nuclease digestion of nuclei reveals extended nucleosome ladders having anomalous DNA lengths for chromatin assembled on non-replicating plasmids in transfected cells. , 1994, Nucleic acids research.

[55]  V. Joliot,et al.  Role of transcription factor TFIIF in serum response factor-activated transcription. , 1994, The Journal of biological chemistry.

[56]  P. Farnham,et al.  Start site selection at the TATA-less carbamoyl-phosphate synthase (glutamine-hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter. , 1994, The Journal of biological chemistry.

[57]  R. Tjian,et al.  A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Wang,et al.  Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  P. J. Welch,et al.  A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle , 1993, Cell.

[60]  T. Kouzarides,et al.  The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. , 1993, Nucleic acids research.

[61]  R. Tjian,et al.  Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB , 1993, Cell.

[62]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[63]  J. Nevins,et al.  A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4. , 1993, Molecular and cellular biology.

[64]  W. Kaelin,et al.  E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  P. Farnham,et al.  A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter , 1993, Molecular and cellular biology.

[66]  S. Triezenberg,et al.  Pattern of aromatic and hydrophobic amino acids critical for one of two subdomains of the VP16 transcriptional activator. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  E. Shinya,et al.  A GC box in the bidirectional promoter is essential for expression of the human dihydrofolate reductase and mismatch repair protein 1 genes , 1992, FEBS letters.

[68]  P. Chambon,et al.  Cloning of the 62-kilodalton component of basic transcription factor BTF2. , 1992, Science.

[69]  Marc Vidal,et al.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F , 1992, Cell.

[70]  P. Farnham,et al.  The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter , 1992, Molecular and cellular biology.

[71]  Michael R. Green,et al.  Binding of general transcription factor TFIIB to an acidic activating region , 1991, Nature.

[72]  W. D. Cress,et al.  Critical structural elements of the VP16 transcriptional activation domain. , 1991, Science.

[73]  J. Azizkhan,et al.  Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter , 1990, Molecular and cellular biology.

[74]  C. Ingles,et al.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID , 1990, Nature.

[75]  P. Farnham,et al.  Transcription initiation from the dihydrofolate reductase promoter is positioned by HIP1 binding at the initiation site , 1990, Molecular and cellular biology.

[76]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[77]  M. Ptashne How eukaryotic transcriptional activators work , 1988, Nature.

[78]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[79]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .